Lixte Biotechnology Holdings Inc. (LIXT)
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
Lixte Biotechnology Holdings Inc. (LIXTW)
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
Integra LifeSciences Holdings (IART)
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
PolyPid (PYPD)
PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025
Lexicon Pharmaceuticals Inc. (LXRX)
Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences
Tiziana Life Sciences Ltd. (TLSA)
Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program
Oncotelic Therapeutics, Inc. (OTLC)
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Anticipates Major Fair-Value Uptick Following New Independent JV Valuation
Xenon Pharmaceuticals Inc (XENE)
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
Biomerica Inc. (BMRA)
Biomerica, Inc. - Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS
Biomerica Inc. (BMRA)
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS